The Christie NHS Foundation Trust in Withington, Manchester, manages the Christie Hospital, one of the largest cancer treatment centres of its type in Europe.

During the past decade, The Christie NHS Foundation Trust conducted 530 clinical trials. In the 10-year time frame, 530 clinical trials started and 161 clinical trials were completed, i.e. on average, 30.4% percent of trials that started reached the finish line to date. In the past 5 years, 232 clinical trials started and 114 clinical trials were completed. i.e. 49.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Christie NHS Foundation Trust" #1 sponsor was "The Christie NHS Foundation Trust" with 66 trials, followed by "Hoffmann-La Roche" with 58 trials sponsored, "University College, London" with 42 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 33 trials sponsored and "Pfizer" with 33 trials sponsored. Other sponsors include 584 different institutions and companies that sponsored additional 243 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Christie NHS Foundation Trust" #1 collaborator was "Cancer Research UK" with 49 trials as a collaborator, "AstraZeneca" with 34 trials as a collaborator, "Merck Sharp & Dohme LLC" with 25 trials as a collaborator, "The Christie NHS Foundation Trust" with 23 trials as a collaborator and "University of Manchester" with 14 trials as a collaborator. Other collaborators include 485 different institutions and companies that were collaborators in the rest 323 trials.

According to Clinical.Site data, the most researched conditions in "The Christie NHS Foundation Trust" are "Breast Cancer" (52 trials), "Ovarian Cancer" (38 trials), "Cancer" (31 trials), "Lung Cancer" (25 trials) and "Prostate Cancer" (24 trials). Many other conditions were trialed in "The Christie NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "The Christie NHS Foundation Trust" are "Drug" (637 trials), "Other" (90 trials), "Biological" (85 trials), "Radiation" (69 trials) and "Procedure" (58 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (68 trials), "Atezolizumab" (33 trials), "Gemcitabine" (32 trials), "Paclitaxel" (30 trials) and "Cisplatin" (25 trials). Other intervention names were less common.

The vast majority of trials in "The Christie NHS Foundation Trust" are 702 trials for "All" genders, 80 trials for "Female" genders and 33 trials for "Male" genders.

Currently, there are 336 active trials in "The Christie NHS Foundation Trust". 5 are not yet recruiting, 179 are recruiting, 148 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 322 completed trials in The Christie NHS Foundation Trust, 3 suspended trials, and 84 terminated clinical trials to date.

Out of the total trials that were conducted in The Christie NHS Foundation Trust, 193 "Phase 1" clinical trials were conducted, 349 "Phase 2" clinical trials and 267 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 46 trials that are defined as “Not Applicable".

The Christie NHS Foundation Trust has several departments that took part in Clinical trials: "Christie Hospital NHS Trust, Department of Medical Oncology" - 3 trials, "Christie Hospital NHS Trust; Experimental Cancer Medicine Team" - 3 trials, "Christie Hospital NHS Foundation Trust, GI & Endocrine" - 3 trials, "The Christie NHS Foundation Trust - Medical Oncology" - 2 trials, "The Christie - Dept of Oncology" - 2 trials, "Adult Leukaemia Unit, Christie Hospital" - 2 trials, "Cancer Research UK, Department of Medical Oncology-The Christie NHS Foundation Trust" - 2 trials